Si-Bone (SIBN) Capital Expenditures Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -41.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.17% |
| Dec 31, 2025 | 75.58% |
| Sep 30, 2025 | -28.44% |
| Jun 30, 2025 | -36.21% |
| Mar 31, 2025 | -3.05% |
| Dec 31, 2024 | -504.02% |
| Sep 30, 2024 | 56.95% |
| Jun 30, 2024 | -33.07% |
| Mar 31, 2024 | 1.76% |
| Dec 31, 2023 | -22.45% |
| Sep 30, 2023 | -73.64% |
| Jun 30, 2023 | 207.88% |
| Mar 31, 2023 | 267.41% |
| Dec 31, 2022 | -117.94% |
| Sep 30, 2022 | 68.55% |
| Jun 30, 2022 | 38.51% |
| Mar 31, 2022 | 153.25% |
| Dec 31, 2021 | -66.21% |
| Sep 30, 2021 | -291.38% |
| Jun 30, 2021 | 172.82% |
| Mar 31, 2021 | 108.50% |
| Dec 31, 2020 | 96.31% |